VEGF Signal Complexity Confers Resistance to Atezolizumab, Bevacizumab, Carboplatin, and Paclitaxel in EGFR-Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer.

Saved in:
Bibliographic Details
Title: VEGF Signal Complexity Confers Resistance to Atezolizumab, Bevacizumab, Carboplatin, and Paclitaxel in EGFR-Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer.
Authors: Hong S; Research Institute National Cancer Center Gyeonggi Republic of Korea., Yu N; Research Institute National Cancer Center Gyeonggi Republic of Korea., Cho JY; Research Institute National Cancer Center Gyeonggi Republic of Korea., Lee GK; Center for Lung Cancer National Cancer Center Hospital Gyeonggi-do Republic of Korea., Ahn BC; Research Institute National Cancer Center Gyeonggi Republic of Korea.; Center for Lung Cancer National Cancer Center Hospital Gyeonggi-do Republic of Korea., Lee Y; Research Institute National Cancer Center Gyeonggi Republic of Korea.; Center for Lung Cancer National Cancer Center Hospital Gyeonggi-do Republic of Korea., Sim H; National Cancer Center Graduate School of Cancer Science and Policy Gyeonggi Republic of Korea., Song BR; Research Institute National Cancer Center Gyeonggi Republic of Korea., Hwang M; Research Institute National Cancer Center Gyeonggi Republic of Korea., Kim S; Research Institute National Cancer Center Gyeonggi Republic of Korea., Kim JH; Research Institute National Cancer Center Gyeonggi Republic of Korea., Park C; Research Institute National Cancer Center Gyeonggi Republic of Korea., Han JY; Research Institute National Cancer Center Gyeonggi Republic of Korea.; Center for Lung Cancer National Cancer Center Hospital Gyeonggi-do Republic of Korea.
Source: MedComm [MedComm (2020)] 2025 Aug 19; Vol. 6 (9), pp. e70335. Date of Electronic Publication: 2025 Aug 19 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: John Wiley & Sons, Inc Country of Publication: China NLM ID: 101769925 Publication Model: eCollection Cited Medium: Internet ISSN: 2688-2663 (Electronic) Linking ISSN: 26882663 NLM ISO Abbreviation: MedComm (2020) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2688-2663
DOI:10.1002/mco2.70335